Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Association of Serum Infliximab and Antibodies Toward Infliximab (ATI) to Clinical Outcomes in Crohn's Disease

NCT01438151 is registered in ClinicalTrials.gov with Shradha Agarwal as lead sponsor.

NCT NCT01438151
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01438151 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Association of Serum Infliximab and Antibodies Toward Infliximab (ATI) to Clinical Outcomes in Crohn's Disease
Lead sponsor
Shradha Agarwal
Phase
Not applicable
Overall status
Terminated
Start date
December 31, 2011
Completion date
December 31, 2013
Enrollment
11 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

crohn's disease